focus -WSS

focus

author：leisure time 2025-10-01 00:59:44 - browse：424

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Key Senate committee drafts bipartisan bill to stem drug shortages

WSS

FTC falls short on scrutinizing hospital mergers, study says

Nearly two

Diversity in clinical trials starts with building trust, experts say

What the cancer research community can learn from the Covid response

MassMutual is introducing free genetic testing for members

ProMED, early warning system on disease outbreaks, in peril

leisure time

focus

hotspot

Peter Hotez and the public health issue of online harassment

Gilgo Beach: Police identify another victim in serial killing investigation

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

Virginia high school admissions case could be legal follow

Orangutan used medicinal plant to treat wound, first time ever seen

Jerome Adams on the need for new antivirals for Covid

TytoCare raises $49 million to build out AI

Bright Health sells Medicare Advantage business to Molina

ProMED, early warning system on disease outbreaks, in peril

focus

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Cholera vaccine supply gets boost as demand surges globally

What Mike Pence has said that could be used in a Donald Trump trial

MassMutual is introducing free genetic testing for members

Verily hires former Apple Health leader as chief scientific officer

hotspot

hotspot

explore

focus